Pharmacokinetic Properties of Various Modified Release Tablet Formulations of Lu AF11167

NCT02260830 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
28
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

H. Lundbeck A/S